Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting Post published:September 30, 2022 Post category:Press Release
Psyence Group Completes Export of Psilocybin Mushrooms to Portugal Post published:September 30, 2022 Post category:Press Release
Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Post published:September 30, 2022 Post category:Press Release
PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022 Post published:September 29, 2022 Post category:Press Release
Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer Post published:September 28, 2022 Post category:Press Release
MindMed Announces Pricing of Public Offering of Common Shares and Warrants Post published:September 28, 2022 Post category:Press Release
Mindset Pharma Provides Strategic Intellectual Property License to Cybin Post published:September 28, 2022 Post category:Press Release
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock Post published:September 28, 2022 Post category:Press Release
MindMed Announces Proposed Public Offering of Common Shares Post published:September 28, 2022 Post category:Press Release
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives Post published:September 27, 2022 Post category:Press Release